ARCHIVES

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

FDA to elevate oncology to office level, consolidate most cancer programs. Search planned for oncologist to head new office.

July 23, 2004

NCI-Frederick Leases Office Building To Move Some Programs Off Army Base.

February 26, 2010

DRG Regulation Opponents May Have Powerful New Ally

November 25, 1983

Screening Frequency for Cervical Cancer May Be Reduced, ACS Says

November 22, 2002

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014